-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Keros Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
- Keros Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $5.7M, a 48.5% increase year-over-year.
- Keros Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $22.5M, a 73.1% increase year-over-year.
- Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $16.9M, a 67.6% increase from 2022.
- Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $10.1M.
- Keros Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$360K, a 132% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)